Rezolute (RZLT) Accumulated Expenses (2011 - 2026)
Rezolute's (RZLT) quarterly Accumulated Expenses came in at $1.0 million in Q1 2026, down 0.96% year-on-year from $1.0 million in Q1 2025, and down 32.51% quarter-over-quarter from $1.5 million in Q4 2025.
Rezolute (RZLT) Accumulated Expenses (2011 - 2026) Analysis & Trends
Rezolute has disclosed Accumulated Expenses across 16 years of filings, most recently posting $1.0 million for Q1 2026.
- Accumulated Expenses for Q1 2026 came in at $1.0 million, down 0.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (down 0.96% YoY), and the FY2025 annual result was $2.3 million, up 25.22% from the prior year.
- Accumulated Expenses came in at $1.0 million for Q1 2026 at Rezolute, down from $1.5 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $4.0 million in Q4 2024 to a low of $450000.0 in Q1 2022.
- The 5-year median for Accumulated Expenses is $1.7 million (2023), against an average of $1.9 million.
- Across the five-year window, Accumulated Expenses soared 150.0% in 2022 and plunged 61.5% in 2025, its largest moves.
- Rezolute's Accumulated Expenses stood at $2.2 million in 2022, then advanced by 11.15% to $2.5 million in 2023, then soared by 60.25% to $4.0 million in 2024, then slumped by 61.5% to $1.5 million in 2025, then slumped by 32.51% to $1.0 million in 2026.
- The last three Accumulated Expenses figures came in at $1.0 million (Q1 2026), $1.5 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 1.53 Mn |
| Sep 30, 2025 | 3.32 Mn |
| Jun 30, 2025 | 2.27 Mn |
| Mar 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | 3.98 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | 1.81 Mn |
| Mar 31, 2024 | 879,000.00 |
| Dec 31, 2023 | 2.48 Mn |
| Sep 30, 2023 | 1.68 Mn |
| Jun 30, 2023 | 883,000.00 |
| Dec 31, 2022 | 2.23 Mn |
| Mar 31, 2022 | 450,000.00 |
| Dec 31, 2021 | 1.47 Mn |
| Jun 30, 2021 | 77,000.00 |
| Mar 31, 2021 | 180,000.00 |
| Dec 31, 2020 | 1.26 Mn |
| Sep 30, 2020 | 79,000.00 |
| Jun 30, 2020 | 120,000.00 |